{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-008064","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2022-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.908207+00:00","generated_at":"2026-06-21T12:48:00.940771+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CNS Pharmaceuticals effects 1-for-30 reverse stock split to meet Nasdaq listing requirement","bullets":["Reverse stock split effective Nov 28, 2022 at 4:01 PM ET; trading on split-adjusted basis begins Nov 29, 2022.","Outstanding shares reduced from ~40.03M to ~1.33M; authorized shares remain at 75M.","Purpose: increase per-share price to comply with Nasdaq minimum bid price requirement.","No fractional shares; rounding up to whole share; CUSIP changes to 18978H201.","Outstanding warrants, options, and RSUs adjusted proportionally; par value unchanged at $0.001."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-008064","json":"https://secwatch.observer/filing/0001683168-22-008064.json","markdown":"https://secwatch.observer/filing/0001683168-22-008064.md","text":"https://secwatch.observer/filing/0001683168-22-008064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316822008064/0001683168-22-008064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316822008064/cns_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T12:48:00.940771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ec47e7da55b79254d5f74005668f14efe7f20a57","claim":"CNS Pharmaceuticals, Inc.: Approved amendment to articles of incorporation to effect a 1-for-30 reverse stock split (effective 2022-11-28).","evidence_excerpt":"The Amendment was filed with the Secretary of State of the State of Nevada and the Reverse Stock Split will become effective in accordance with the terms of the Amendment at 4:01 p.m. Eastern Time on November 28, 2022 (the “Effective Time”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1729427/000168316822008064/0001683168-22-008064-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2022-11-28"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}